Trends and perioperative mortality in gastric cancer surgery: a nationwide population‑based cohort study

被引:0
作者
Roberto Peltrini
Barbara Giordani
Giorgia Duranti
Renato Salvador
Mario Costantini
Francesco Corcione
Umberto Bracale
Giovanni Baglio
机构
[1] University of Naples Federico II,Department of Public Health, School of Medicine and Surgery
[2] Italian National Agency for Regional Healthcare Services,Research and International Relations Unit
[3] University of Padua,Department of Surgical, Oncological and Gastroenterological Sciences
[4] University of Salerno,Department of Medicine, Surgery and Dentistry
来源
Updates in Surgery | 2023年 / 75卷
关键词
Gastric cancer; Laparoscopy; Gastrectomy; Mortality; Hospital volume;
D O I
暂无
中图分类号
学科分类号
摘要
This study aimed to investigate changes and perioperative mortality over a 6-year period within the Italian Hospital Information System among patients with gastric cancer (GC) who underwent gastrectomies and to identify risk factors associated with 90-day mortality. Additionally, nationwide differences between high and low-volume hospitals were evaluated. A nationwide retrospective study was conducted using patient hospital discharge records (HDRs) based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) classification. The HDRs were linked to the National Tax Registry records using deterministic record linkage. The data were obtained from the Italian National Outcomes Evaluation Programme (PNE). Multivariate logistic regression was used to examine risk factors for 90-day mortality among patients with GC who underwent partial or total gastrectomies over the period from 2018 to 2020 with adjustment for comorbidities. Overall, the number of patients with GC who underwent total or partial gastrectomies steadily decreased in Italy from 5765 in 2015 to 4291 in 2020 (p < 0.001). The use of the laparoscopic approach more than doubled from 2015 (10.8%) to 2020 (26.3%), with a concomitant conversion rate from laparoscopy to open surgery decreasing from 7.7 to 5.8%. The 30 and 90-day mortality rates remained stable over time (p > 0.05). Low-volume hospitals had higher inpatient, early, and late mortality compared to high-volume hospitals (5.9% vs 3.8%, 6.3% vs 3.8%, and 11.8% vs 7.9%, respectively; p < 0.001). Multivariate logistic regression analysis showed that an advanced age (adjusted odds ratio: 3.72; 95% [CI]: 3.15–4.39; p < 0.001), an open approach (adjusted-OR: 1.69, 95% CI: 1.43–1.99, p < 0.001) and a total gastrectomy (adjusted-OR: 1.44, 95% CI: 1.27–1.64, p < 0.001) were independent risk factors for 90-day mortality. Additionally, patients with GC who referred to high-volume hospitals were 26% less likely to die within 90 days after a gastrectomy than those who underwent surgery in low-volume hospitals. During the 6-year period, surgeons implemented a minimally invasive approach to reduce the conversion over time. Centralisation was associated with better outcomes while advanced age, an open approach, and total gastrectomy were identified as risk factors for 90-day mortality.
引用
收藏
页码:1873 / 1879
页数:6
相关论文
共 118 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
Ferlay J(2020)The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017 Lancet Gastroenterol Hepatol. 5 42-54
[3]  
Soerjomataram I(2022)Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up Ann Oncol 33 1005-1020
[4]  
Siegel RL(2019)Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial JAMA 321 1983-1992
[5]  
Torre LA(2020)Long-Term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial J Clin Oncol 38 3304-3313
[6]  
Jemal A(2021)Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial Gastric Cancer 24 258-271
[7]  
Lordick F(2017)Minimally invasive surgery for gastric cancer: the American experience Gastric Cancer 20 368-378
[8]  
Carneiro F(2022)Laparoscopic gastrectomy for stage II and III advanced gastric cancer: long-term follow-up data from a Western multicenter retrospective study Surg Endosc 36 2300-2311
[9]  
Cascinu S(2002)Hospital volume and surgical mortality in the United States N Engl J Med 346 1128-1137
[10]  
Yu J(2019)Effect of hospital volume with respect to performing gastric cancer resection on recurrence and survival: results from the CRITICS trial Ann Surg 270 1096-1102